MiR-15a/16 regulates the growth of myeloma cells, angiogenesis and antitumor immunity by inhibiting Bcl-2, VEGF-A and IL-17 expression in multiple myeloma-Reference-Cited by-同舟云学术

MiR-15a/16 regulates the growth of myeloma cells, angiogenesis and antitumor immunity by inhibiting Bcl-2, VEGF-A and IL-17 expression in multiple myeloma

Published:2016-10 Issue: Volume:49 Page:73-79
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Li Yanjie,Zhang Bingyun,Li Wenjing,Wang Lijin,Yan Zhiling,Li Hujun,Yao Yao,Yao Ruosi,Xu Kailin,Li Zhenyu

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference46 articles.

1. Bone marrow angiogenesis and progression in multiple myeloma;Vacca;Br. J. Haematol.,1994

2. Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization;Zojer;Blood,2000

3. Potential relationship and clinical significance of miRNAs and Th17 cytokines in patients with multiple myeloma;Li;Leuk. Res.,2014

4. Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results;Harrison;Br. J. Haematol.,2003

5. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia;Calin;Proc. Natl. Acad. Sci. U. S. A.,2002

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in RNA cancer therapeutics: New insight into exosomes as miRNA delivery;Aspects of Molecular Medicine;2023

2. The Multiple Myeloma Landscape: Epigenetics and Non-Coding RNAs;Cancers;2022-05-10

3. Non-coding RNA-based regulation of inflammation;Seminars in Immunology;2022-01

4. MicroRNAs as potential immunotherapeutic modulators in cancer;Clinical Applications of Immunogenetics;2022

5. Epigenetic Modifications in Myeloma: Focused Review of Current Data and Potential Therapeutic Applications;Indian Journal of Medical and Paediatric Oncology;2021-10